Advertisement

Topics

Blanchette Rockefeller Neurosciences Institute (BRNI) Company Profile

01:52 EDT 20th September 2017 | BioPortfolio


News Articles [949 Associated News Articles listed on BioPortfolio]

ProMIS Neurosciences: ProMIS Neurosciences Completes First Closing of Private Placement

/NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, ONTARIO - August 9, 2017 - ProMIS Neurosciences Inc. ("ProMIS" or the "Company") (TSX:PMN; OTCPK:A...

ProMIS Neurosciences: ProMIS Neurosciences Increases Size of Private Placement to $6 Million

/NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, ONTARIO - August 2, 2017 - ProMIS Neurosciences Inc. ("ProMIS" or the "Company") (TSX:PMN; OTCPK:A...

ProMIS Neurosciences: ProMIS Neurosciences Announces CDN$3 Million Best-Efforts Private Placement

/NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, ON - July 20, 2017 - ProMIS Neurosciences Inc. ("ProMIS" or the "Company") (TSX:PMN; OTCPK:ARFX.F;...

ProMIS Neurosciences: ProMIS Neurosciences Appoints William C. Mobley to Scientific Advisory Board

TORONTO and CAMBRIDGE, Mass., June 06, 2017 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX:PMN), a biotechnology company focused on the discovery and development of precision treatments for n...

Minerva Neurosciences, Inc.: Minerva Neurosciences, Inc. to Offer Common Shares

WALTHAM, Mass., 2017-06-27 22:10 CEST (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company, today announced its intention to offer and sell 5,00...

ProMIS Neurosciences: ProMIS Neurosciences Announces Q1 2017 Annual Results

TORONTO, Ontario - May 9, 2017 - ProMIS Neurosciences, Inc. (TSX:PMN) ("ProMIS" or the "Company"), a company focused on the discovery and development of precision treatments for neurodegenerative ...

ProMIS Neurosciences: ProMIS Neurosciences Announces Second Quarter 2017 Results

TORONTO and CAMBRIDGE, Mass., Aug. 11, 2017 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. ("ProMIS" or the "Company"), a company focused on the discovery and development of precision treatments f...

Minerva Neurosciences, Inc.: Minerva Neurosciences Announces Pricing of Public Offering of Common Stock

WALTHAM, Mass., 2017-06-29 00:45 CEST (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten publi...

Drugs and Medications [31 Associated Drugs and Medications listed on BioPortfolio]

Eczenil [Healingsmith Institute Inc.]

Myobloc [Solstice Neurosciences, LLC]

Myobloc (rimabotulinumtoxinB) Injection

Psoracare [Healingsmith Institute Inc.]

Elliotts b [QOL Medical LLC]

ELLIOTTS B SOLUTION (buffered intrathecal electrolyte/dextrose injection) Rx Only

Clinpro 5000 [3M ESPE Dental Products]

These highlights do not include all the information needed to use 3M™ ESPE™ Clinpro 5000 Anti-Cavity Toothpaste safely and effectively. See full prescribing information for Clinpro 5000 Anti-Cavit...

PubMed Articles [618 Associated PubMed Articles listed on BioPortfolio]

An amended history of tissue culture: Concerning Harrison, Burrows, Mall, and Carrel.

The origin of tissue culture is commonly dated to 1907 and credited to Ross Harrison at Hopkins Medical School. But an unpublished letter from the 1942 offers a different interpretation and gives prio...

At the Intersection of Chemistry, Biology, and Medicine.

After an undergraduate degree in biology at Harvard, I started graduate school at The Rockefeller Institute for Medical Research in New York City in July 1965. I was attracted to the chemical side of ...

The Tanenbaum Open Science Institute: Leading a Paradigm Shift at the Montreal Neurological Institute.

The Montreal Neurological Institute is adopting an Open Science Policy that will be enacted by the Tanenbaum Open Science Institute. The aim is to accelerate the generation of knowledge and novel effe...

Toxicity of spinosad to temephos-resistant Aedes aegypti populations in Brazil.

The mosquito Aedes aegypti is the primary vector of different arboviruses and represents a major public health problem. Several Brazilian populations of Ae. aegypti have developed resistance to temeph...

The surge of predatory open-access in neurosciences and neurology.

Predatory open access is a controversial publishing business model that exploits the open-access system by charging publication fees in the absence of transparent editorial services. The credibility o...

Clinical Trials [509 Associated Clinical Trials listed on BioPortfolio]

The Effect of Nighttime Dialysis on the Inflammation of Kidney Failure

This study will determine whether a new form of home hemodialysis carried out at night during sleep reduces blood levels of hormone-like substances called cytokines that may cause fatigue ...

Enhancing Social Interaction With an AlterEgo Artificial Agent

The objective of AlterEgo is the creation of an interactive cognitive architecture, implementable in various artificial agents, allowing a continuous interaction with patients suffering fr...

Postmenopausal Estrogen/Progestin Interventions (PEPI)

To assess the effects of various postmenopausal estrogen replacement therapies on selected cardiovascular risk factors, including high density lipoprotein cholesterol, systolic blood press...

Understanding Male Breast Cancer: Salah Azaïz Cancer Institute Experience

The goal of this study is to evaluate the Salah Azaïz Cancer Institute male breast cancer patients population over a period of 14 years. Goal of the retrospective part: to gather clinico...

Evaluation and Treatment of People With Eye Diseases

This study will evaluate and provide standard treatments for people with various eye conditions. It will provide a resource for enrollment into new research protocols throughout the Eye In...

Companies [1189 Associated Companies listed on BioPortfolio]

Blanchette Rockefeller Neurosciences Institute (BRNI)

Blanchette Rockefeller Neurosciences Institute

Brain Injury Research Institute

The Brain Injury Research Institute is a center for the study of traumatic brain injuries and prevention, which is affiliated with the Blanchette Rockefeller Neuroscience Institute at West Virginia Un...

Venrock Associates

Venrock was founded as the venture capital arm of the Rockefeller Family and continues a six-decade tradition of funding outstanding entrepreneurs and establishing successful, enduring companies. Venr...

Merz Neurosciences

Merz Neurosciences is a division of Merz North America, a specialty healthcare company that develops and commercializes treatment solutions in aesthetics, dermatology and neurosci...

More Information about "Blanchette Rockefeller Neurosciences Institute (BRNI)" on BioPortfolio

We have published hundreds of Blanchette Rockefeller Neurosciences Institute (BRNI) news stories on BioPortfolio along with dozens of Blanchette Rockefeller Neurosciences Institute (BRNI) Clinical Trials and PubMed Articles about Blanchette Rockefeller Neurosciences Institute (BRNI) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Blanchette Rockefeller Neurosciences Institute (BRNI) Companies in our database. You can also find out about relevant Blanchette Rockefeller Neurosciences Institute (BRNI) Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record